Jubilant Pharmova Cash Flow Annual

Trade
BSE: 530019 | NSE: JUBLPHARMA | ISIN: INE700A01033 | Sector: Biotechnology & Drugs
722.60 -10.20 (-1.39%)Updated : 21 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 170.5027.78630.45871.08
Depreciation/ Depletion 381.90554.03381.70451.65
Non- Cash Items 373.50228.85197.77605.76
Changesin Working Capital 45.40-149.99-372.38-221.21
Cashfrom Operating Activities 971.30660.67837.541,707.28
Capital Expenditures -897.70-814.45-599.99-527.49
Other Investing Cash Flow Items Total 289.80270.04219.62-211.52
Cashfrom Investing Activities -607.90-544.41-380.37-739.01
Financing Cash Flow Items -243.70-234.23-134.94-292.24
Total Cash Dividends Paid -79.80-80.06-80.05-1.48
Issuance( Retirement)of Stock Net -27.40-3.970.00-10.06
Issuance( Retirement)of Debt Net -81.60161.58182.39-1,405.62
Cashfrom Financing Activities -432.50-156.68-32.60-1,709.39
Foreign Exchange Effects 11.6070.5357.2912.26
Net Changein Cash -57.5030.10481.86-728.86
Cash Interest Paid 243.70234.23134.94292.24
Cash Taxes Paid 207.70204.30194.09394.12
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,413.25+32.10(2.32%)
1,531.70+16.40(1.08%)
10,662.95-242.55 (-2.22%)
3,533.10-64.00 (-1.78%)
HomeMarketsPremiumInstant LoanGet App